期刊文献+

老年男性慢性心力衰竭患者血清BNP、T和FT3水平测定及意义 被引量:3

下载PDF
导出
摘要 目的:探讨老年男性慢性心力衰竭患者血清脑钠肽(BNP)、睾酮(T)和游离三碘甲状腺原氨酸(FT3)三者水平的变化及其之间的相关性。方法:选择心功能Ⅱ级患者35例,Ⅲ级患者30例,Ⅳ级患者34例,分别测定其BNP、T、FT3水平及左室射血分数(LVEF)、24小时动态心电图。对照组为同期体检健康者98例。结果:(1)心衰组血清中BNP、T、FT3分别为:224.64±123.12,4.73±0.82,3.57±0.41;对照组分别为85.68±2.90,8.26±0.43,5.24±0.58;两组3项指标比较差异均有统计学意义(P<0.01)。(2)心功能Ⅱ、Ⅲ、Ⅳ级组间比较BNP水平依次升高(P<0.01)、T水平依次降低(P<0.01)、FT3水平依次降低(P<0.01)。(3)左心室射血分数(LVEF33.06±8.42%)与血清BNP呈负相关(r=-0.28,P<0.05)、与T水平呈正相关(r=0.0364,P<0.01)、与FT3水平呈正相关(r=0.188,P<0.05);心衰组恶性心律失常组的BNP、T及FT3水平均与非恶性心律失常组差异有统计学意义(P<0.05)。结论:男性心衰患者随着心功能的恶化程度升高,BNP逐渐升高,T、FT3进行性下降,测定三者水平有助于临床治疗方案的确定及预后的判断。
作者 孙彩琴
出处 《交通医学》 2014年第2期124-126,共3页 Medical Journal of Communications
  • 相关文献

参考文献3

二级参考文献110

  • 1吴小盈,沈冰,蒋文平,宋建平.慢性心力衰竭患者血浆B型利钠肽的测定及治疗的影响[J].心血管康复医学杂志,2005,14(6):527-529. 被引量:33
  • 2Wingard DL, Suarez L, Barrett-Conor E. The sex differential in mortality from all causes and ischaemic heart disease. Am J Epidemiol1983; l17: 165-72.
  • 3Njolstad I, Arnesen E, Lund-Larsen PG. Smoking, serum lipids, blood pressure, and sex differences in myocardial infarction. A 12-year follow-up of the Finnmark Study. Circulation 1996; 93: 450-6.
  • 4Kannel WB, Hjortland MC, McNamara PM, Gordon T. Menopause and risk of cardiovascular disease: The Framingham Study. Ann Intern Med 1976; 85: 447-52.
  • 5Kritz-Silverstein D, Barrett-Connor E, Wingard DL. Hysterectomy, oophorectomy, and heart disease risk factors in older women. Am J Public Health 1997; 87: 676-80.
  • 6Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE et at. Menopause and the risk of coronary heart disease in women. N EnglJ Med 1987; 316: 1105-10.
  • 7Misso ML, Murata Y, Boon WC, Jones ME, Britt KL et al. Cellular and molecular characterization of the adipose phenotype of the aromatase-deficient mouse. Endocrin%gy2003; 144: 1474-80.
  • 8La Vecchia C, Decarli A, Franceschi S, Gentile A, Negri E et at. Menstrual and reproductive factors and the risk 01 myocardial infarction in women under fifty-five years of age. Am J Obstet Gynecol1987; 157: 1108-12.
  • 9Hulley S, Grady D, Bush T, FurbergC, Herrington D et at. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogenlprogestin Replacement Study (HERS) Research Group. JAMA 1998; 280: 605-13.
  • 10Writing Group for the Womens Health Initiative. Risks and benefits of estrogen plus progestin in healthy postmenopauseal women. JAMA 2002; 288: 321-33.

共引文献42

同被引文献36

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部